Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000892569-03-001453
Filing Date
2003-06-04
Accepted
2003-06-04 14:02:15
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a87286a3e10vkza.htm 10-K/A 69113
3 EXHIBIT 10.37 a87286a3exv10w37.txt EX-10.37 57888
4 EXHIBIT 10.38 a87286a3exv10w38.txt EX-10.38 57484
5 EXHIBIT 10.39 a87286a3exv10w39.txt EX-10.39 56201
6 EXHIBIT 10.42 a87286a3exv10w42.txt EX-10.42 58596
7 EXHIBIT 10.43 a87286a3exv10w43.txt EX-10.43 53035
8 EXHIBIT 99.1 a87286a3exv99w1.txt EX-99.1 1130
9 EXHIBIT 99.2 a87286a3exv99w2.txt EX-99.2 1137
  Complete submission text file 0000892569-03-001453.txt   357032
Mailing Address 15279 ALTON PARKWAY 100 IRVINE CA 92618
Business Address 15279 ALTON PARKWAY 100 IRVINE CA 92618 9497886000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31255 | Film No.: 03732167
SIC: 2835 In Vitro & In Vivo Diagnostic Substances